MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

12 Feb 2026 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended December 2025. The figure stood at Rs. 0.00 millions during the year-ago period.The Total Profit for the quarter ended December 2025 of Rs. 4.63 millions grew from Rs.-3.14 millions Operating profit Margin for the quarter ended December 2025 improved to 4.63% as compared to -3.14% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 15.43 -0.91 -1795.60 8.38 23.82 -64.82
Other Income 5.42 2.28 137.72 4.37 -4.22 -203.55 0.00 0.00 0.00
PBIDT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 4.63 -3.14 -247.45 13.17 -14.69 -189.65 -2.93 19.31 -115.17
Equity 902.60 652.60 38.31 902.60 652.60 38.31 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 85.35 1614.29 -94.71 -34.96 81.07 -143.13
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..